Influence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas

被引:21
|
作者
Stegmayr, Carina [1 ]
Bandelow, Ulrike [1 ]
Oliveira, Dennis [1 ]
Lohmann, Philipp [1 ]
Willuweit, Antje [1 ]
Filss, Christian [1 ,2 ]
Galldiks, Norbert [1 ]
Luebke, Joachim H. R. [1 ]
Shah, N. Jon [1 ,2 ,3 ]
Ermert, Johannes [1 ,2 ]
Langen, Karl-Josef [1 ,2 ]
机构
[1] Forschungszentrum Julich, Inst Neurosci & Med, D-52425 Julich, Germany
[2] RWTH Univ Hosp Aachen, Dept Nucl Med & Neurol, Aachen, Germany
[3] JARA, Sect JARA Brain, Aachen, Germany
关键词
PET; Brain tumors; O-(2-[F-18]fluoroethyl)-L-tyrosine (F-18-FET); Blood brain barrier (BBB); Dexamethasone; VALUABLE DIAGNOSTIC-TOOL; UPTAKE KINETICS; INTRACRANIAL TUMORS; RECURRENT GLIOMA; CEREBRAL GLIOMAS; GRADE GLIOMA; F-18-FET PET; AMINO-ACID; EVANS BLUE; FET PET;
D O I
10.1007/s00259-016-3508-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose O-(2-F-18-fluoroethyl)-L-tyrosine (F-18-FET) is an established tracer for the diagnosis of brain tumors with PET. This study investigates the influence of blood-brain barrier (BBB) permeability on F-18-FET uptake in two rat glioma models and one human xenograft model. Methods F98 glioma, 9L gliosarcoma or human U87 glioblastoma cells were implanted into the striatum of 56 Fischer or RNU rats. Thereafter, animals were divided into a control group and a group receiving injections of the glucocorticoid dexamethasone (Dex). After 12-13 days of tumor growth animals received injection of Evans blue dye (EBD) to visualize BBB disturbance and underwent F-18-FET PET followed by autoradiography. Time activity curves, standardized uptake values (SUV) and Tumor-to-brain ratios (TBR) of F-18-FET uptake [ 18-61 min post injection (p. i.)] were evaluated using a volume-of-Interest (VOI) analysis. BBB disturbance was quantitatively evaluated by EBD fluorescence. The membrane gaps of blood vessel endothelial tight junctions were measured using electron microscopy to visualize ultrastructural BBB alterations in one untreated and one Dex treated F98 glioma. Data were analyzed by two-way ANOVAs. Results In Dex treated animals EBD extravasation was significantly reduced in 9L (P < 0.001) andU87 (P = 0.008) models and showed a trend in F98 models (P = 0.053). In contrast, no significant differences of F-18-FET uptake were observed between Dex treated animals and control group except a decrease of the TBR in the 9L tumor model in PET (P < 0.01). Ultrastructural evaluation of tumor blood vessel endothelia revealed significant reduction of the cleft diameter between endothelial cells after Dex treatment in F98 model (P = 0.010). Conclusion Despite a considerable reduction of BBB permeability in rat gliomas after Dex treatment, no relevant changes of F-18-FET uptake were noted in this experimental study. Thus, F-18-FET uptake in gliomas appears to be widely independent of the permeability of the BBB.
引用
收藏
页码:408 / 416
页数:9
相关论文
共 50 条
  • [41] Metabolic imaging of cerebral gliomas:: Spatial correlation of changes in O-(2-18F-fluoroethyl)L-tyrosine PET and proton magnetic resonance spectroscopic imaging
    Stadlbauer, Andreas
    Prante, Olaf
    Nimsky, Christopher
    Salomonowitz, Erich
    Buchfelder, Michael
    Kuwert, Torsten
    Linke, Rainer
    Ganslandt, Oliver
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (05) : 721 - 729
  • [42] Sensitivity of intraoperative 5-aminolevulinic acid fluorescence compared with PET using O-(2-18F-fluoroethyl)-L-tyrosine to detect cerebral gliomas
    Langen, Karl-Josef
    Floeth, Frank W.
    Galldiks, Norbert
    [J]. NEUROLOGICAL RESEARCH, 2013, 35 (03) : 329 - 330
  • [43] O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis
    Heinzel, Alexander
    Mueller, Dirk
    Yekta-Michael, Sareh Said
    Ceccon, Garry
    Langen, Karl-Josef
    Mottaghy, Felix M.
    Wiesmann, Martin
    Kocher, Martin
    Hattingen, Elke
    Galldiks, Norbert
    [J]. NEURO-ONCOLOGY, 2017, 19 (09) : 1271 - 1278
  • [44] O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients
    Santonocito, Orazio S.
    Grimod, Gianluca
    Di Stefano, Anna L.
    Pieri, Francesco
    Nizzola, Mariagrazia
    Mazzuca, Nicola
    Pasqualetti, Francesco
    Morganti, Riccardo
    Zucchi, Vanna
    Gambacciani, Carlo
    [J]. JOURNAL OF NEUROSURGICAL SCIENCES, 2023,
  • [45] REPEATABILITY OF O-(2-18F-FLUOROETHYL)-L-TYROSINE POSITRON EMISSION TOMOGRAPHY (FET-PET) SCANNING AND THE INFLUENCE OF PROTEIN INTAKE IN GLIOMA
    Chehri, Sarah
    Henriksen, Otto Molby
    Marner, Lisbeth
    Christensen, Mette
    Poulsen, Hans
    Law, Ian
    [J]. NEURO-ONCOLOGY, 2018, 20 : 188 - 188
  • [46] The diagnostic accuracy of O-(2-18F-fluoroethyl)-L-tyrosine parameters for the differentiation of brain tumour progression from treatment-related changes
    Diao, Wei
    Su, Dunyan
    Cao, Yuan
    Jia, Zhiyun
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (03) : 350 - 358
  • [47] Treatment-Related Uptake of O-(2-18F-Fluoroethyl)-L-Tyrosine and L-[Methyl-3H]-Methionine After Tumor Resection in Rat Glioma Models
    Geisler, Stefanie
    Stegmayr, Carina
    Niemitz, Nicole
    Lohmann, Philipp
    Rapp, Marion
    Stoffels, Gabriele
    Willuweit, Antje
    Galldiks, Norbert
    Filss, Christian
    Sabel, Michael C.
    Coenen, Heinz H.
    Shah, Nadim Jon
    Langen, Karl-Josef
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (10) : 1373 - 1379
  • [48] Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy
    Ceccon, Garry
    Lohmann, Philipp
    Stoffels, Gabriele
    Judov, Natalie
    Filss, Christian P.
    Rapp, Marion
    Bauer, Elena
    Hamisch, Christina
    Ruge, Maximilian I.
    Kocher, Martin
    Kuchelmeister, Klaus
    Sellhaus, Bernd
    Sabel, Michael
    Fink, Gereon R.
    Shah, Nadim J.
    Langen, Karl-Josef
    Galldiks, Norbert
    [J]. NEURO-ONCOLOGY, 2017, 19 (02) : 281 - 288
  • [49] Quantification of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in glioma
    Thomas Koopman
    Niels Verburg
    Robert C. Schuit
    Petra J. W. Pouwels
    Pieter Wesseling
    Albert D. Windhorst
    Otto S. Hoekstra
    Philip C. de Witt Hamer
    Adriaan A. Lammertsma
    Ronald Boellaard
    Maqsood Yaqub
    [J]. EJNMMI Research, 8
  • [50] Pituitary Incidentaloma Found on O-(2-F-18-Fluoroethyl)-L-Tyrosine PET
    Currie, Geoffrey M.
    Trifunovic, Marko
    Kiat, Hosen
    Saunders, Catherine
    Chung, David
    Ong, Yang-Yi
    Wilkinson, Mark
    Witte, Karin
    Magnussen, John
    [J]. JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2014, 42 (03) : 218 - 222